{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:57:52Z","timestamp":1781614672083,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P50HL084948"],"award-info":[{"award-number":["P50HL084948"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL128289"],"award-info":[{"award-number":["1R01HL128289"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>COPD is associated with an increased AFib-related morbidity and mortality. There are several AFib risk prediction models available, but none have been validated in the COPD population. Our study aims to identify spirometric and radiographic variables that are associated with an increased risk of AFib. Secondarily, we hope to determine if these associated variables improve the risk discrimination of established AFib risk prediction models in individuals with COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We evaluated 755 participants from a single center tobacco-exposed cohort at baseline. At this study visit, the following were performed: demographic, medical history, and symptom questionnaires, PFT, and CT imaging. We performed logistic regression analysis to determine cardiopulmonary variables associated with prevalent AFib. The multivariable analysis was adjusted for sex, age, number of pack years, BMI, self-reported heart failure, and anti-hypertensive medication use. Exposure variables that were statistically significant in the logistic regression analysis were added in succession to current AFib risk prediction models, CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc and CHARGE-AF, to create updated models. C-statistics were calculated for both risk scores alone as well as with each updated model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DLco (OR 0.40, CI 0.18\u20130.86), heart volume (OR 13.12, CI 2.32\u201374.17), percentage of emphysema (OR 2.77, CI 1.04\u20137.40), and mMRC (OR 1.17, CI 1.02\u20131.35) were associated with prevalent AFib in the multivariable logistic regression analysis. When conducting the discrimination analysis of the AFib risk prediction scores, the addition of these cardiopulmonary variables improved CHARGE-AF, from C-statistic 0.53 to 0.63 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified cardiopulmonary factors associated with an increased risk of AFib in a tobacco-exposed cohort. The incorporation of lung function, CT parameters, and symptom scores in validated AFib prediction models may improve AFib risk discrimination in our chronic lung disease populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>not applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was supported by the National Institute of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) grants 1R01HL128289 (J.B.) and P50HL084948 (F.C.S.).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-025-03366-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:31:54Z","timestamp":1761042714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing atrial fibrillation risk prediction in an observational cohort of tobacco-exposed individuals: the role of pulmonary function tests, symptom scores, and imaging"],"prefix":"10.1186","volume":"26","author":[{"given":"Nicole","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mehdi","family":"Nouraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K","family":"Leader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C","family":"Sciurba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"130","key":"3366_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","volume":"22","author":"A Cavaill\u00e8s","year":"2013","unstructured":"Cavaill\u00e8s A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454\u201375. https:\/\/doi.org\/10.1183\/09059180.00008612.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"3366_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030743","volume":"13","author":"DF Mariniello","year":"2024","unstructured":"Mariniello DF, D\u2019Agnano V, Cennamo D, et al. Comorbidities in COPD: current and future treatment challenges. J Clin Med. 2024;13(3):743. https:\/\/doi.org\/10.3390\/jcm13030743.","journal-title":"J Clin Med"},{"key":"3366_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2018.09.056","volume":"276","author":"M Grymonprez","year":"2019","unstructured":"Grymonprez M, Vakaet V, Kavousi M, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118\u201324. https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.056.","journal-title":"Int J Cardiol"},{"key":"3366_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.hrtlng.2021.09.001","volume":"51","author":"J Ye","year":"2022","unstructured":"Ye J, Yao P, Shi X, Yu X. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome. Heart Lung. 2022;51:67\u201374. https:\/\/doi.org\/10.1016\/j.hrtlng.2021.09.001.","journal-title":"Heart Lung"},{"issue":"5","key":"3366_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","volume":"69","author":"CA Goudis","year":"2017","unstructured":"Goudis CA. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J Cardiol. 2017;69(5):699\u2013705. https:\/\/doi.org\/10.1016\/j.jjcc.2016.12.013.","journal-title":"J Cardiol"},{"issue":"35","key":"3366_CR6","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1093\/eurheartj\/ehab453","volume":"42","author":"GF Romiti","year":"2021","unstructured":"Romiti GF, Corica B, Pipitone E, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab453.","journal-title":"Eur Heart J"},{"issue":"2","key":"3366_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.000102","volume":"2","author":"A Alonso","year":"2013","unstructured":"Alonso A, Krijthe BP, Aspelund T, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102. https:\/\/doi.org\/10.1161\/JAHA.112.000102.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"3366_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.amjmed.2016.02.029","volume":"129","author":"W Saliba","year":"2016","unstructured":"Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS\u2082 and CHA\u2082DS\u2082-VASc scores in the prediction of new-onset atrial fibrillation: A population-based study. Am J Med. 2016;129(8):843\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2016.02.029.","journal-title":"Am J Med"},{"issue":"4","key":"3366_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2478\/rjim-2021-0018","volume":"59","author":"AM Louka","year":"2021","unstructured":"Louka AM, Tsagkaris C, Stoica A. Clinical risk scores for the prediction of incident atrial fibrillation: a modernized review. Rom J Intern Med. 2021;59(4):321\u20137. https:\/\/doi.org\/10.2478\/rjim-2021-0018.","journal-title":"Rom J Intern Med"},{"issue":"7","key":"3366_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1164\/rccm.201004-0666OC","volume":"183","author":"J Bon","year":"2011","unstructured":"Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011;183(7):885\u201390. https:\/\/doi.org\/10.1164\/rccm.201004-0666OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3366_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pulmoe.2021.06.001","volume":"29","author":"R Pisi","year":"2023","unstructured":"Pisi R, Aiello M, Calzetta L, et al. The COPD assessment test and the modified medical research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients. Pulmonology. 2023;29(3):194\u20139. https:\/\/doi.org\/10.1016\/j.pulmoe.2021.06.001.","journal-title":"Pulmonology"},{"issue":"6","key":"3366_CR12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343. https:\/\/doi.org\/10.1183\/09031936.00080312.","journal-title":"Eur Respir J"},{"issue":"3","key":"3366_CR13","doi-asserted-by":"publisher","first-page":"1700010","DOI":"10.1183\/13993003.00010-2017","volume":"50","author":"S Stanojevic","year":"2017","unstructured":"Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):1700010. https:\/\/doi.org\/10.1183\/13993003.00010-2017.","journal-title":"Eur Respir J"},{"issue":"3","key":"3366_CR14","doi-asserted-by":"publisher","first-page":"2000289","DOI":"10.1183\/13993003.00289-2020","volume":"57","author":"GL Hall","year":"2021","unstructured":"Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, et al. Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J. 2021;57(3):2000289. https:\/\/doi.org\/10.1183\/13993003.00289-2020.","journal-title":"Eur Respir J"},{"issue":"4","key":"3366_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90224-8","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332. https:\/\/doi.org\/10.1016\/0735-1097(90)90224-8.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3366_CR16","doi-asserted-by":"publisher","first-page":"051806","DOI":"10.1117\/1.JMI.10.5.051806","volume":"10","author":"L Pu","year":"2023","unstructured":"Pu L, Leader JK, Ali A, et al. Predicting left\/right lung volumes, thoracic cavity volume, and heart volume from subject demographics to improve lung transplant. J Med Imaging (Bellingham). 2023;10(5):051806. https:\/\/doi.org\/10.1117\/1.JMI.10.5.051806.","journal-title":"J Med Imaging (Bellingham)"},{"key":"3366_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2022.102367","volume":"77","author":"J Pu","year":"2022","unstructured":"Pu J, Leader JK, Sechrist J, et al. Automated identification of pulmonary arteries and veins depicted in non-contrast chest CT scans. Med Image Anal. 2022;77:102367. https:\/\/doi.org\/10.1016\/j.media.2022.102367.","journal-title":"Med Image Anal"},{"key":"3366_CR18","doi-asserted-by":"publisher","unstructured":"American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;81(6):e247-350. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.017","DOI":"10.1016\/j.jacc.2022.10.017"},{"key":"3366_CR19","volume-title":"Stata statistical software: release 18. College station","author":"StataCorp","year":"2023","unstructured":"StataCorp. Stata statistical software: release 18. College station. TX: StataCorp LLC; 2023."},{"issue":"9596","key":"3366_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"4","key":"3366_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.chest.2022.05.004","volume":"162","author":"RR Parikh","year":"2022","unstructured":"Parikh RR, Norby FL, Wang W, Thenappan T, Prins KW, Van\u2019t Hof JR, et al. Association of right ventricular afterload with atrial fibrillation risk in older adults: the atherosclerosis risk in communities study. Chest. 2022;162(4):884\u201393. https:\/\/doi.org\/10.1016\/j.chest.2022.05.004.","journal-title":"Chest"},{"issue":"7","key":"3366_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071917","volume":"11","author":"J Grebe","year":"2022","unstructured":"Grebe J, M\u00fcller T, Altiok E, Becker M, Keszei AP, Marx N, et al. Effects of COPD on left ventricular and left atrial deformation in patients with acute myocardial infarction: strain analysis using speckle-tracking echocardiography. J Clin Med. 2022;11(7):1917. https:\/\/doi.org\/10.3390\/jcm11071917.","journal-title":"J Clin Med"},{"issue":"9","key":"3366_CR23","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","volume":"114","author":"PS Chen","year":"2014","unstructured":"Chen PS, Chen LS, Fishbein MC, Lin SF. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500\u201315. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.303772.","journal-title":"Circ Res"},{"key":"3366_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2016.05.004","volume":"178","author":"IE Christophersen","year":"2016","unstructured":"Christophersen IE, Yin X, Larson MG, et al. A comparison of the CHARGE\u2013AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J. 2016;178:45\u201354. https:\/\/doi.org\/10.1016\/j.ahj.2016.05.004.","journal-title":"Am Heart J"},{"issue":"11","key":"3366_CR25","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jacep.2019.06.016","volume":"5","author":"OL Hulme","year":"2019","unstructured":"Hulme OL, Khurshid S, Weng LC, et al. Development and validation of a prediction model for atrial fibrillation using electronic health records. JACC Clin Electrophysiol. 2019;5(11):1331\u201341. https:\/\/doi.org\/10.1016\/j.jacep.2019.06.016.","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03366-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:29:20Z","timestamp":1781612960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03366-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3366"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03366-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6439820\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines. The SCCOR study was approved by the University of Pittsburgh ethics and review board. All participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}